Funding for this research was provided by:
National Institutes of Health (U01CA185188, R01GM123766, U01CA194730, R01MD012392)
Received: 3 September 2019
Accepted: 19 March 2020
First Online: 30 March 2020
Ethics approval and consent to participate
: In this study, liver tissues from 30 adult patients recruited at Medstar Georgetown University Hospital (MGUH), Washington, DC were used. The study is conducted through a protocol approved by the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) Institutional Review Board (IRB), Washington, DC, under Protocol # 2014–0059 “Multi-omic Approaches for Liver Cancer Biomarker Discovery.” The collection and use of the tissues was approved by the IRB of Georgetown University, Washington, DC, under Protocol #2007–345 “Establishment of the High Quality Tumor Biobank and Clinical Database”. All patients signed a consent form permitting the use of donated tissue. The consent forms and their content were reviewed and approved by the IRB.
: Not Applicable.
: The authors declare that they have no competing interests.